Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential

Lancet. 2020 Nov 21;396(10263):1611-1613. doi: 10.1016/S0140-6736(20)32259-5. Epub 2020 Oct 27.

WHO Ad Hoc Clinical Trial Expert Group:
P R Krause, T Fleming, M M Alejandria, B Bhargava, S Ellenberg, P J Garcia, E Halloran, A M Henao-Restrepo, I Longini, M C Miranda Montoya, M Roses, H Sommerfelt

¹ Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
² University of Washington, Fred Hutchinson Cancer Centre, Seattle, WA, USA.
³ Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
⁴ Health Emergencies Programme, World Health Organization, CH-1211 Geneva 27, Switzerland. Electronic address: henaorestrepoa@who.int.

No abstract available

Publication types